CELLFUSE - Trademark Details
Status: 700 - Registered
Serial Number
88245691
Registration Number
6120774
Word Mark
CELLFUSE
Status
700 - Registered
Status Date
2020-08-04
Filing Date
2018-12-31
Registration Number
6120774
Registration Date
2020-08-04
Mark Drawing
4000 - Standard character mark
Typeset
Attorney Name
Law Office Assigned Location Code
L70
Employee Name
FAUCETTE, MAX CLIFFORD
Statements
Goods and Services
Medical devices, namely, devices to aspirate bone marrow and harvest autologous bone dowels; synthetic bone graft substitute materials; medical apparatus for the delivery of the combination of bone marrow, autologous bone dowels and bone graft material to the surgical site; medical device pack consisting of a combination of medical devices and materials, namely, devices to aspirate bone marrow and harvest autologous bone dowels, synthetic bone graft substitute materials, and medical apparatus for the delivery of the combination of bone marrow, autologous bone dowels and bone graft material to the surgical site
Pseudo Mark
CELL FUSE
Classification Information
International Class
010 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials. - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
US Class Codes
026, 039, 044
Class Status Code
6 - Active
Class Status Date
2019-01-22
Primary Code
010
First Use Anywhere Date
2019-08-01
First Use In Commerce Date
2019-10-01
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Correspondences
Name
Arvid von Taube
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2019-01-03 | NEW APPLICATION ENTERED IN TRAM |
2019-01-22 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2019-03-20 | ASSIGNED TO EXAMINER |
2019-04-25 | NON-FINAL ACTION WRITTEN |
2019-04-25 | NON-FINAL ACTION E-MAILED |
2019-04-25 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2019-08-19 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2019-08-19 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2019-08-20 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2019-09-11 | FINAL REFUSAL WRITTEN |
2019-09-11 | FINAL REFUSAL E-MAILED |
2019-09-11 | NOTIFICATION OF FINAL REFUSAL EMAILED |
2020-03-06 | TEAS AMENDMENT OF USE RECEIVED |
2020-03-09 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
2020-03-16 | ASSIGNED TO LIE |
2020-03-17 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2020-03-17 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2020-03-06 | USE AMENDMENT FILED |
2020-06-03 | AMENDMENT TO USE PROCESSING COMPLETE |
2020-06-24 | USE AMENDMENT ACCEPTED |
2020-06-24 | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER |
2020-06-25 | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED |
2020-07-01 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2020-08-04 | REGISTERED-SUPPLEMENTAL REGISTER |